Notes
The study was supported by Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck.
Reference
Yan T, et al. Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy. Clinical Therapeutics : 10 Jan 2020. Available from: URL: http://doi.org/10.1016/j.clinthera.2019.11.009
Rights and permissions
About this article
Cite this article
Brexpiprazole reduces costs of psychiatric care in the US. PharmacoEcon Outcomes News 845, 4 (2020). https://doi.org/10.1007/s40274-020-6507-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6507-0